CytomX Therapeutics, Inc.·4

Jun 15, 5:47 PM ET

GLUCK FREDERICK W 4

4 · CytomX Therapeutics, Inc. · Filed Jun 15, 2018

Insider Transaction Report

Form 4
Period: 2018-06-13
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-06-13+14,00014,000 total
    Exercise: $25.25Exp: 2028-06-12Common Stock (14,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    271,643
  • Common Stock

    (indirect: By Spouse)
    3,200
  • Common Stock

    (indirect: By LLC)
    22,111
Footnotes (3)
  • [F1]The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997.
  • [F2]Richlin Partners, LLC is an entity owned of record by the spouse of the Reporting Person.
  • [F3]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Documents

2 files